The speed of the development pipeline only adds to the challenge as GLP1 therapies are being used for approved indications beyond diabetes and obesity, including heart, liver and renal disease. With these evolving usage patterns, plan sponsors face a coverage dilemma defined by constant change and escalating financial exposure
When these nerve cells were killed, the drugs effect on appetite and fat loss instead decreased significantly
Gallagher EJ, Sun H, Kornhauser C, Tobin-Hess A, Epstein S, Yakar S, et al
Rubbing can cause friction and redness in your underarms and folds
S7A, GLP-1RA intervention was associated with a reduction in total cholesterol when compared to placebo (MD = 0.04